Heterogeneity in patterns of progression of chronic kidney disease

被引:12
作者
Abeysekera, Rajitha A. [1 ,2 ,3 ]
Healy, Helen G. [2 ,3 ]
Wang, Zaimin [3 ,4 ]
Cameron, Anne L. [2 ,3 ,4 ]
Hoy, Wendy E. [3 ,4 ]
机构
[1] Univ Peradeniya, Fac Med, Dept Med, Peradeniya, Sri Lanka
[2] Metro North Hosp & Hlth Serv, Kidney Hlth Serv, Queensland Hlth, Herston, Qld, Australia
[3] Univ Queensland, CKD QLD & NHMRC CKD CRE Collaborat, Fac Med, Brisbane, Qld, Australia
[4] Univ Queensland, Fac Med, Ctr Chron Dis, Sch Clin Med, Brisbane, Qld, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
chronic kidney disease; progression; definitions; proteinuria; NATURAL-HISTORY; RENAL-DISEASE; PROTEINURIA; DECLINE; DIET; GFR;
D O I
10.1111/imj.14770
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Progression of kidney disease is a deceptively simple word for a complex bio-clinical process, evidenced by the number of definitions in the literature. This has led to confusion and differences in interpretation of studies. Methods We describe different patterns of progression, the performance of different definitions of progression and factors associated with chronic kidney disease (CKD) progression in a public renal service in Australia, in a study of patients enrolled in the CKD.QLD Registry with a minimum of 2 years' follow up. Results Nine patterns of changing estimated glomerular filtration rate (eGFR) over two consecutive 12-month periods were identified. Most common was a stable eGFR over 2 years (30%), and the least was a sustainable improvement of eGFR over both periods (2.1%). There was a lack of congruence between the several definitions of progression of CKD evaluated. More people progressed using the definition of decline of eGFR of >5 mL/min/1.73 m(2)/year (year 1 = 30.2%, year 2 = 20.7%) and the least using development of end-stage renal disease (year 1 = 5.4%, year 2 = 9.9%). Age (40-59, >= 80 years), degree of proteinuria at baseline (nephrotic range) and CKD aetiology (renal vascular disease, diabetic nephropathy) were significantly associated with eGFR decline over 2 years. Conclusions This is one of the first demonstrations of the great variations among and within individuals in the progression of CKD over even a period as short as 2 years. Findings suggest considerable potential for renal function recovery and stability while demonstrating the importance of using identical definitions for comparisons across datasets from different sources.
引用
收藏
页码:220 / 228
页数:9
相关论文
共 23 条
[1]   Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans [J].
Appel, Lawrence J. ;
Wright, Jackson T., Jr. ;
Greene, Tom ;
Kusek, John W. ;
Lewis, Julia B. ;
Wang, Xuelei ;
Lipkowitz, Michael S. ;
Norris, Keith C. ;
Bakris, George L. ;
Rahman, Mahboob ;
Contreras, Gabriel ;
Rostand, Stephen G. ;
Kopple, Joel D. ;
Gabbai, Francis B. ;
Schulman, Gerald I. ;
Gassman, Jennifer J. ;
Charleston, Jeanne ;
Agodoa, Lawrence Y. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (08) :832-839
[2]   Prevalence of kidney damage in Australian adults: The AusDiab Kidney Study [J].
Chadban, SJ ;
Briganti, EM ;
Kerr, PG ;
Dunstan, DW ;
Welborn, TA ;
Zimmet, PZ ;
Atkins, RC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :S131-S138
[3]  
Coppo R, 2005, J NEPHROL, V18, P503
[4]   Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality [J].
Coresh, Josef ;
Turin, Tanvir Chowdhury ;
Matsushita, Kunihiro ;
Sang, Yingying ;
Ballew, Shoshana H. ;
Appel, Lawrence J. ;
Arima, Hisatomi ;
Chadban, Steven J. ;
Cirillo, Massimo ;
Djurdjev, Ognjenka ;
Green, Jamie A. ;
Heine, Gunnar H. ;
Inker, Lesley A. ;
Irie, Fujiko ;
Ishani, Areef ;
Ix, Joachim H. ;
Kovesdy, Csaba P. ;
Marks, Angharad ;
Ohkubo, Takayoshi ;
Shalev, Varda ;
Shankar, Anoop ;
Wen, Chi Pang ;
de Jong, Paul E. ;
Iseki, Kunitoshi ;
Stengel, Benedicte ;
Gansevoort, Ron T. ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (24) :2518-2531
[5]   Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment [J].
de Goeij, Moniek C. M. ;
Liem, Madieke ;
de Jager, Dinanda J. ;
Voormolen, Nora ;
Sijpkens, Yvo W. J. ;
Rotmans, Joris I. ;
Boeschoten, Elisabeth W. ;
Dekker, Friedo W. ;
Grootendorst, Diana C. ;
Halbesma, Nynke .
NEPHRON CLINICAL PRACTICE, 2012, 121 (1-2) :C73-C82
[6]   The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age [J].
Eriksen, BO ;
Ingebretsen, OC .
KIDNEY INTERNATIONAL, 2006, 69 (02) :375-382
[7]   The Natural History of the Non-Nephrotic Membranous Nephropathy Patient [J].
Hladunewich, Michelle A. ;
Troyanov, Stephan ;
Calafati, Jennifer ;
Cattran, Daniel C. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (09) :1417-1422
[8]   Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study [J].
Hunsicker, LG ;
Adler, S ;
Caggiula, A ;
England, BK ;
Greene, T ;
Kusek, JW ;
Rogers, NL ;
Teschan, PE .
KIDNEY INTERNATIONAL, 1997, 51 (06) :1908-1919
[9]   Longitudinal Progression Trajectory of GFR Among Patients With CKD [J].
Li, Liang ;
Astor, Brad C. ;
Lewis, Julia ;
Hu, Bo ;
Appel, Lawrence J. ;
Lipkowitz, Michael S. ;
Toto, Robert D. ;
Wang, Xuelei ;
Wright, Jackson T., Jr. ;
Greene, Tom H. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (04) :504-512
[10]   LONGITUDINAL-STUDIES ON THE RATE OF DECLINE IN RENAL-FUNCTION WITH AGE [J].
LINDEMAN, RD ;
TOBIN, J ;
SHOCK, NW .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1985, 33 (04) :278-285